Zomedica Corp (ZOMDF) Q3 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the Zomedica Q3 2024 Financial Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, November 7th of 2024. I would now like to turn the conference over to Mike Valli. Please go ahead. Thank you, Robert, and good afternoon, ladies and gentlemen. Welcome to Zamedica's third quarter 2024 earnings results and business update call. Joining me on today's call are Zamedica's chief executive officer, Larry Heaton, and its vice president and corporate controller, Mike Zelke. Before we begin, we would like to remind everyone that on this call, we will be making various remarks about future expectations, plans, and prospects that constitute forward-looking statements. These forward-looking statements are based on assumptions, and there are risks that results may differ materially from those statements. As such, Dometica cannot guarantee that any forward-looking statements will materialize, and you are cautioned not to place undue reliance on them. We refer current and potential investors to the forward-looking information and risk factor sections of our public filings available on CDAR Plus at www.cdarplus.ca and on edgar.sec.gov. Forward-looking statements made on this conference call represent Zomedica's expectations as of today, November 7, 2024. I will now pass the call over to Zomedica's Chief Executive Officer, Larry Heaton. Larry? Thanks, Mike. I'd like to start by thanking our shareholders for your support, wishing prospective investors, analysts, and others a good afternoon, and...